Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
The Journal of the American Osteopathic Association
|
October 3, 2007
Overactive bladder: treatment options in primary care medicine
David O Sussman
The Journal of the American Osteopathic Association
|
April 16, 2004
Pharmacokinetics, pharmacodynamics, and efficacy of phosphodiesterase type 5 inhibitors
David O Sussman
The Journal of the American Osteopathic Association
|
March 25, 2004
A current review of medical therapy for benign prostatic hyperplasia
Gordon A Brown, David O Sussman
JAAPA : Official Journal of the American Academy of Physician Assistants
|
December 1, 2005
Contemporary treatment options for overactive bladder
Paul H Taylor, David O Sussman
Reviews in Urology
|
November 27, 2018
Management Options for Nocturia at a Large Urology Group Practice
David M Albala, David O Sussman
Current Medical Research and Opinion
|
April 5, 2007
Onset of efficacy of tolterodine extended release in patients with overactive bladder
David O Sussman, Stephen R Kraus, Martin Carlsson, et al.
The Journal of the American Osteopathic Association
|
March 19, 2011
Human papillomavirus testing in men
Kathleen F McGinley, Wayne Hey, David O Sussman, et al.
Urology
|
October 26, 2010
Safety and efficacy of once-daily trospium chloride extended-release in male patients with overactive bladder
Scott A MacDiarmid, Pamela I Ellsworth, David A Ginsberg, et al.
Cureus
|
March 16, 2026
HbA1c as a Predictor of Complications in Anterior and Posterior Colporrhaphy
Alexandra McQuillen, Vaishnavi J Patel, Devki Patel, et al.
The Journal of Urology
|
July 22, 2008
Effect of tolterodine extended release with or without tamsulosin on measures of urgency and patient reported outcomes in men with lower urinary tract symptoms
Eric S Rovner, Karl Kreder, David O Sussman, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
The Journal of the American Osteopathic Association
|
October 3, 2007
Overactive bladder: treatment options in primary care medicine
David O Sussman
The Journal of the American Osteopathic Association
|
April 16, 2004
Pharmacokinetics, pharmacodynamics, and efficacy of phosphodiesterase type 5 inhibitors
David O Sussman
The Journal of the American Osteopathic Association
|
March 25, 2004
A current review of medical therapy for benign prostatic hyperplasia
Gordon A Brown, David O Sussman
JAAPA : Official Journal of the American Academy of Physician Assistants
|
December 1, 2005
Contemporary treatment options for overactive bladder
Paul H Taylor, David O Sussman
Reviews in Urology
|
November 27, 2018
Management Options for Nocturia at a Large Urology Group Practice
David M Albala, David O Sussman
Current Medical Research and Opinion
|
April 5, 2007
Onset of efficacy of tolterodine extended release in patients with overactive bladder
David O Sussman, Stephen R Kraus, Martin Carlsson, et al.
The Journal of the American Osteopathic Association
|
March 19, 2011
Human papillomavirus testing in men
Kathleen F McGinley, Wayne Hey, David O Sussman, et al.
Urology
|
October 26, 2010
Safety and efficacy of once-daily trospium chloride extended-release in male patients with overactive bladder
Scott A MacDiarmid, Pamela I Ellsworth, David A Ginsberg, et al.
Cureus
|
March 16, 2026
HbA1c as a Predictor of Complications in Anterior and Posterior Colporrhaphy
Alexandra McQuillen, Vaishnavi J Patel, Devki Patel, et al.
The Journal of Urology
|
July 22, 2008
Effect of tolterodine extended release with or without tamsulosin on measures of urgency and patient reported outcomes in men with lower urinary tract symptoms
Eric S Rovner, Karl Kreder, David O Sussman, et al.
Page
of 2